Match Group director Bronstein Manuel acquires dividend shares
Bronstein Manuel, director at Match Group, acquires 29 dividend equivalents, raising his total holdings to 64 shares, signaling continued investment in the tech sector.
Jones Reports Stock Transaction at Match Group, Inc.
Laura Rachel Jones of Match Group, Inc. reported a stock transaction involving 17 shares and dividend equivalents, reflecting ongoing ownership activity.
Harris Parker Acquires 1,785 Shares of Salesforce Stock
Harris Parker reported a transaction involving 1,785 shares of Salesforce common stock, signaling continued confidence in the company's future.
McInerney acquires shares in Match Group via dividend equivalents
Thomas McInerney reports acquisition of 29 shares in Match Group, reflecting confidence in the company's future. Full details in the SEC filing.
Zeta Global CFO Greiner Reports Major Stock Transactions
Zeta Global's CFO, Christopher E. Greiner, reports significant stock transactions, reflecting strategic shifts in executive compensation and ownership.
Match Group director Glenn Schiffman reports stock transactions
Glenn Schiffman, a director at Match Group, Inc., reports stock transactions involving shares and dividend equivalents, highlighting his ongoing engagement with the company.
Nippon Life Insurance Co. Acquires 193,357 Shares in Corebridge
Nippon Life Insurance Co. has purchased over 193,000 shares of Corebridge Financial, signaling confidence in the company's future in the life insurance sector.
Match Group CFO Bailey Steven Richard Jr. Acquires Shares
CFO Bailey Steven Richard Jr. of Match Group, Inc. reports acquisition of 429 shares through dividend equivalents, reflecting industry compensation trends.
Garceau Exercises Stock Options for 7,585 Shares at Sherwin-Williams
Mary L. Garceau of Sherwin-Williams exercises stock options for 7,585 shares, reflecting confidence in the company's future amid industry trends.
Veralto CEO Jennifer Honeycutt Acquires Shares in Company
Veralto Corp's CEO Jennifer Honeycutt recently acquired shares, signaling confidence in the company's future and stability in the testing instruments industry.
Gerber Steven H. Reports Major Stock Transactions in Zeta Global
Gerber Steven H. discloses significant stock transactions in Zeta Global Holdings, emphasizing performance-based incentives and executive compensation alignment.
Buckle Inc SVP Scott A. Werth sells 2,500 shares of stock
Scott A. Werth of Buckle Inc sold 2,500 shares of stock, reflecting ongoing changes in executive holdings within the retail clothing industry.
Bailey Stephen acquires 29 dividend equivalents in Match Group
Bailey Stephen reports a transaction acquiring 29 dividend equivalents in Match Group, raising his total shares to 64, signaling confidence in the company.
Ann McDaniel acquires 29 shares in Match Group via dividend
Ann McDaniel has acquired 29 shares of Match Group through dividend equivalents, increasing her total shares to 64. This reflects her commitment to the company.
Fong Morgan Reports Stock Transactions Under Trading Plan
Fong Morgan, Chief Legal Officer of Maplebear Inc., discloses stock transactions under a trading plan, impacting the business services sector.
Young Wendy B. Acquires 3,789 Shares in Rapport Therapeutics
Young Wendy B. increases her stake in Rapport Therapeutics by acquiring 3,789 shares, signaling confidence in the pharmaceutical sector.
Fuller Gilbert A acquires shares in USANA Health Sciences
Gilbert A. Fuller reports acquisition of shares and restricted stock units in USANA Health Sciences, reflecting ongoing investment in the company.
Jaye James R acquires shares through stock options at Sherwin Williams
Jaye James R reports acquisition of 2,335 shares via stock options at Sherwin Williams, emphasizing executive incentives in the retail-building materials sector.
Cavens Darrell acquires shares in Match Group, Inc.
Cavens Darrell's recent share acquisition in Match Group, Inc. signals ongoing commitment and engagement with the company.
Immunovant CTO Sells Shares to Cover Tax Obligations
Immunovant's CTO, Jay Stout, sells shares to cover tax obligations from vested stock, reflecting ongoing equity management in the biological products sector.